Showing results (1251-1260 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|March 9, 2024
Nutritional Strategies To Improve VRE ControlEnrico Morello, Sara Roversi, Giulia Brambilla, et al.Transplantation and Cellular Therapy|March 6, 2024
Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular ImmunotherapyCheri Adams, Michael Keller, Jennifer G Michlitsch, et al.Transplantation and Cellular Therapy|March 6, 2024
Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation CyclophosphamideAndie Fu, Yizhou Peng, Ping Cheng, et al.Transplantation and Cellular Therapy|February 27, 2024
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.Transplantation and Cellular Therapy|February 22, 2024
Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic MalignancyRebecca Epperly, Ying Li, Subodh Selukar, et al.Transplantation and Cellular Therapy|November 19, 2023
Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018Bryan Valcarcel, Sara J Schonfeld, Christa L Meyer, et al.Transplantation and Cellular Therapy|October 27, 2023
Real-World Outcomes with Chimeric Antigen Receptor T Cell Therapies in Large B Cell Lymphoma: A Systematic Review and Meta-AnalysisCaron A Jacobson, Javier Munoz, Fang Sun, et al.Transplantation and Cellular Therapy|November 12, 2023
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation CyclophosphamideHany Elmariah, Salman Otoukesh, Ambuj Kumar, et al.Transplantation and Cellular Therapy|November 6, 2023
Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS SyndromeAn-An Li, Xue-Min Gao, Hao Zhao, et al.Transplantation and Cellular Therapy|November 6, 2023
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic LeukemiaGabriela Llaurador, Kristen Shaver, Mengfen Wu, et al.Pageof 183